2025 Japan Antimicrobial Susceptibility Testing Market Revenue Opportunities Report
Description
The 2025 Japan Antimicrobial Susceptibility Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antimicrobial Susceptibility Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Antimicrobial Susceptibility Testing (AST) market in Japan include bioMérieux, Thermo Fisher Scientific, Danaher Corporation, and HiMedia Laboratories. BioMérieux is a global leader known for its extensive range of AST products and automated platforms widely used in Japanese clinical diagnostics. Thermo Fisher Scientific offers robust AST instruments and consumables, supporting rapid and accurate testing. Danaher Corporation, through its subsidiaries like Beckman Coulter and Leica Microsystems, provides state-of-the-art diagnostic technologies vital for antimicrobial resistance detection. HiMedia Laboratories, an Indian multinational with operations in Japan, supplies culture media and reagents essential for AST procedures, particularly in automated testing segments.
These companies are capitalizing on Japan's growing demand for efficient antimicrobial susceptibility testing due to increasing antimicrobial resistance concerns and the need for precise, timely diagnostics. The market in Japan is characterized by rising adoption of automated AST instruments that provide rapid and reproducible results, reducing turnaround time in hospital and research settings. Automated systems from these firms facilitate high-throughput processing and standardized testing, critical for managing infectious diseases. Additionally, the Japanese market's growth at a CAGR of about 5.6% signals expanding healthcare investments and innovation supporting AST technology development and deployment. Sysmex Corporation, another major Japanese player, recently won the UK's Longitude Prize for its rapid AST system, underscoring Japan's role in AST innovation.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Antimicrobial Susceptibility Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Antimicrobial Susceptibility Testing (AST) market in Japan include bioMérieux, Thermo Fisher Scientific, Danaher Corporation, and HiMedia Laboratories. BioMérieux is a global leader known for its extensive range of AST products and automated platforms widely used in Japanese clinical diagnostics. Thermo Fisher Scientific offers robust AST instruments and consumables, supporting rapid and accurate testing. Danaher Corporation, through its subsidiaries like Beckman Coulter and Leica Microsystems, provides state-of-the-art diagnostic technologies vital for antimicrobial resistance detection. HiMedia Laboratories, an Indian multinational with operations in Japan, supplies culture media and reagents essential for AST procedures, particularly in automated testing segments.
These companies are capitalizing on Japan's growing demand for efficient antimicrobial susceptibility testing due to increasing antimicrobial resistance concerns and the need for precise, timely diagnostics. The market in Japan is characterized by rising adoption of automated AST instruments that provide rapid and reproducible results, reducing turnaround time in hospital and research settings. Automated systems from these firms facilitate high-throughput processing and standardized testing, critical for managing infectious diseases. Additionally, the Japanese market's growth at a CAGR of about 5.6% signals expanding healthcare investments and innovation supporting AST technology development and deployment. Sysmex Corporation, another major Japanese player, recently won the UK's Longitude Prize for its rapid AST system, underscoring Japan's role in AST innovation.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
